Neurobehavioral Development Professors and Supervisors | ApplySharif

جست‌وجوی استاد و پژوهشگر

استاد راهنما، استاد دانشگاه یا پژوهشگر مناسب برای مسیر پژوهشی‌تان را پیدا کنید و با او ارتباط بگیرید.

نمایش ۷۲۱-۷۳۵ از ۱٬۳۵۱ استاد راهنما

اطلاعات این پروفایل‌ها از صفحات عمومی دانشگاه‌ها جمع‌آوری شده و ممکن است به‌روز نباشد.

Amy Arnoldمشاهده پروفایل

دانشیار

Penn State College of MedicineUnited States

Amy Arnold, PhD is an Associate Professor in the Department of Neuroscience and Experimental Therapeutics at Penn State University College of Medicine. She is also affiliated with the Penn State Neuroscience Institute and the Center for Cannabis and Natural Product Pharmaceuticals (CCNPP). Her research focuses on understanding how the brain controls blood pressure and energy balance, with particular emphasis on angiotensin-(1-7) interactions with the brain to improve blood pressure and insulin sensitivity in cardiometabolic diseases. Dr. Arnold's laboratory uses a variety of approaches including whole animal in vivo cardiovascular monitoring, pharmacologic and spectral analysis of autonomic function, and measurement of insulin action and energy balance. She also conducts translational studies examining the effects of intravenous angiotensin-(1-7) infusion on blood pressure and flow in patients with obesity, hypertension, and peripheral arterial disease. Her research output shows a strong focus on cardiometabolic diseases, with recent publications examining neurocognitive disorders, atherosclerosis, obesity hypertension, and substance use disorders. The work spans basic science, translational research, and clinical applications, demonstrating a comprehensive approach to understanding cardiovascular and metabolic regulation. Junior Faculty Teaching Award (2021) Outstanding Early (Faculty) Career Development Award (2018) Samuel Hinkle Junior Faculty Research Award (2021) Dr. Arnold serves as Principal Investigator on multiple NIH-funded projects including 'Angiotensin-(1-7) and Cardiovascular Derangements in Obesity Hypertension' and 'Angiotensin-(1-7) and Hypothalamic control of blood pressure.' She holds leadership positions in professional societies including Secretary/Treasurer of the American Society for Pharmacology and Experimental Therapeutics and serves on editorial boards for the American Journal of Hypertension and Physiological Genomics. Her laboratory is actively engaged in studying cardiovascular autonomic disorders including primary autonomic failure, Parkinson's disease, and postural tachycardia syndrome, with particular focus on cognitive dysfunction in these conditions.

پروفایل رسمی دانشگاه

Öznur Özge ÖZCANمشاهده پروفایل

استادیار

Üsküdar UniversityTurkey

Öznur Özge ÖZCAN is an Assistant Professor at the Department of Physiotherapy , Üsküdar University, with a research focus spanning molecular neuroscience, neurobehavioral testing, and nutritional interventions in neurological disorders. She holds a PhD in Molecular Neuroscience (2023) and has contributed to studies involving animal models , neurodegenerative diseases , and peptide-based vaccines . BSc: Physiotherapy and Rehabilitation, Istanbul Bilgi University (2016) MSc: Neuroscience, Uskudar University (2018) PhD: Molecular Neuroscience, Uskudar University (2023) Her research explores neurobehavioral mechanisms in conditions like schizophrenia, autism, and Alzheimer's disease, with recent work on quetiapine's effects on sleep-deprived rats and probiotics in Parkinson's disease . She has also investigated circadian rhythm disruptions in cancer and maternal sleep deprivation impacts. Key trends in her 15 most recent articles include: Preclinical models for psychiatric disorders Nutritional strategies in neurodegeneration Peptide vaccine development Pharmacogenetic studies on caffeine metabolism Computational approaches in cancer treatment Behavioral neuroscience in developmental disorders Administratively, she advises 41-50 students and contributes to research groups in Computational Biology and Biological Activities . Teaching roles include Research Methods , Physiology , and Bioethics at undergraduate and postgraduate levels.

پروفایل رسمی دانشگاه

Anthony J Filianoمشاهده پروفایل

دانشیار

Duke UniversityUnited States

Anthony J Filiano is an Associate Professor in Neurosurgery and Pathology at Duke University, with additional appointments in Integrative Immunobiology. His research investigates the bidirectional communication between immune and nervous systems, focusing on how immune-derived molecules like cytokines influence neural circuits and contribute to neurological disorders including autism spectrum disorder. D.Phil. in Immunobiology, University of Alabama at Birmingham (2009) Postdoctoral Fellow, University of Alabama at Birmingham (2013) Hartwell Fellow, University of Virginia (2013-2017) Key research areas include neuroimmune interactions, cord blood-derived therapies for neurological conditions, and immune cell surveillance in the central nervous system. His lab has pioneered studies on T cell modulation of brain function, mesenchymal stromal cell reprogramming of microglia, and the role of STAT1 signaling in neurobehavioral phenotypes. Recent publications emphasize cord blood applications for remyelination, neuroinflammation suppression, and standardized biobanking of mesenchymal stromal cells. Awards include the Hartwell Fellowship for biomedical research.

پروفایل رسمی دانشگاه

Tone Kristine Hermansenمشاهده پروفایل

پژوهشگر ارشد

University of OsloNorway

Tone Kristine Hermansen is a Postdoctoral Fellow at the Department of Psychology, University of Oslo, specializing in cognitive developmental psychology and social cognitive learning processes. She has previously served as a Postdoctoral Fellow at the Norwegian Center for Child Behavioral Development (2017–2020) and a Fulbright Fellow at Harvard University’s Graduate School of Education (2018–2019). Research Interests: Dr. Hermansen investigates epistemological development in children, focusing on trust revision, empirical reasoning, and emotion attribution. Her work bridges experimental psychology with practical implications for educational practices and developmental psychopathology. Publications & Projects: With over 15 peer-reviewed works, her recent research explores children’s skepticism toward surprising claims, eye-tracking methodology validation, and prenatal SSRI exposure effects. Key projects include Barns informasjonssøking: Utvikling og implikasjoner for læring (Children's information seeking: Development and learning implications) and studies on parenting practices influencing childhood inquiry. Scientific Awards: Fulbright Fellowship (2019) Sasakawa Young Leaders Fellowship (2015) Multiple internal research/teaching grants at the University of Oslo (2015–2024) Student scholarships from The Research Council of Norway (2011–2012) Strategic funding grants as Principal Investigator and co-Investigator (2021–2024)

پروفایل رسمی دانشگاه

Julie Lasselinمشاهده پروفایل

دانشیار

Stockholm UniversitySweden

Julie Lasselin is an Associate Professor at the Department of Psychology, Stockholm University, specializing in Psychoneuroimmunology. She leads research in the Division for Psychoneuroimmunology and the Integrative Science of Sickness research groups, investigating how inflammation influences human behavior and the inter-individual differences in vulnerability to cytokine effects. Dr. Lasselin's research focuses on the complex relationship between the immune system, brain, and behavior. Her work demonstrates that sickness behavior is not merely driven by immune signals but can be shaped by top-down psychological processes. She investigates both overt and subjective behavioral changes induced by inflammation, the adaptive relevance of sickness behavior, and how inflammatory states affect social interactions and subsequent health outcomes. Her research spans experimental endotoxemia models, cross-cultural studies of sickness perception, and translational research connecting inflammation to depression. Analysis of her publication record reveals a strong focus on experimental inflammation models, particularly using lipopolysaccharide challenges to induce controlled inflammatory responses in humans. Her work consistently examines the behavioral, cognitive, and social consequences of inflammation, with growing interest in cross-cultural aspects of sickness behavior and potential applications for understanding inflammation-associated depression. Her scientific achievements include receiving the prestigious PNIRS Ader New Investigator Award in 2021, which recognizes outstanding contributions to Psychoneuroimmunology. This award honors Dr. Ader's innovation and creativity as a scientist and recognizes contributions to advancing PNI as a field dedicated to health improvement and disease prevention. Dr. Lasselin actively contributes to the field through her role on the steering committee and as webmaster of the European Psychoneuroimmunology Network (pnieurope.se). She teaches courses on 'Stress and sleep: from bench to bedside' and leads research projects examining brain and psychological predictors of inflammatory responses and how healthcare provider behavior affects health outcomes. Her work bridges basic science and clinical applications, particularly in understanding how inflammation contributes to neuropsychiatric symptoms. She leads the Integrative Science of Sickness research group, which investigates behavioral changes and feelings occurring during infections. Her laboratory work involves experimental induction of inflammation in humans to precisely measure behavioral, cognitive, and physiological responses, contributing significantly to our understanding of how immune activation translates to sickness behavior in humans.

پروفایل رسمی دانشگاه

Heather R. Adamsمشاهده پروفایل

استاد

University of RochesterUnited States

Dr. Heather R. Adams is a part-time Professor of Neurology and Pediatrics at the University of Rochester Medical Center (URMC) , School of Medicine and Dentistry. Since joining the faculty in 2003, her work has focused on neurobehavioral phenotyping and natural history studies of inherited neurodegenerative diseases like Batten Disease , alongside research into Tourette Syndrome and pediatric hypertension . Ph.D., Southern Illinois University (2002) MA, Southern Illinois University (1995) BA, SUNY Geneseo (1991) Her research spans neurocognitive disorders , tic disorders , and neurodegenerative diseases , with studies on HIV-associated neurocognitive outcomes , congenital heart disease subgroups , and screening tool validation . Articles highlight her expertise in neuropsychological assessments , rare disease clinical trials , and pediatric neurodevelopment . Dr. Adams has received academic honors including Doctoral and Master's Fellowships from Southern Illinois University and membership in Psi Chi . Her work addresses clinical consultation for Batten disease families and telemedicine feasibility in pediatric neurology.

پروفایل رسمی دانشگاه

Namasivayam Ambalavananمشاهده پروفایل

استاد

University of Alabama at BirminghamUnited States

Namasivayam Ambalavanan, M.D. is a Professor and Co-Division Director of Neonatology at the University of Alabama at Birmingham School of Medicine. He holds the Virginia Walker Jones Endowed Chair in Neonatology and serves as Program Director for the Neonatal-Perinatal Fellowship Program. Additionally, he is Director of the Sergio B. Stagno Research Endowment and Director of Neonatal Research. Medical School: Jawaharlal Institute of Post Graduate Medical Education and Research (JIPMER), Pondicherry, India (MBBS) Internship: JIPMER Pondicherry, India Residency: Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India (MD Pediatrics) Fellowship: University of Alabama at Birmingham (Neonatology) Dr. Ambalavanan's research focuses on biomarkers and prediction of outcomes in premature infants, with particular expertise in genomic analyses in bronchopulmonary dysplasia (BPD) and prediction models for extremely premature outcomes. His work spans basic science, translational research, and clinical investigations, with over 300 publications to date (90 as first or senior author). As Director of the Translational Research in Normal and Disordered Development (TReNDD) Program, he leads a comprehensive research program addressing neonatal lung development and injury. Analysis of his recent publications (2025) reveals a strong emphasis on neonatal respiratory outcomes, particularly bronchopulmonary dysplasia and pulmonary hypertension in preterm infants. His research increasingly incorporates genomic, multiomic, and biomarker approaches to understand disease mechanisms and improve prediction models. A significant portion of his current work focuses on the impact of prenatal opioid exposure on neonatal outcomes, reflecting his leadership in the NIH HEAL initiative. His clinical trials work spans respiratory support strategies, caffeine therapy, and fluid management protocols for vulnerable neonatal populations. Virginia Walker Jones Endowed Chair in Neonatology Principal Investigator for one of five NIH Pre-VENT research centers Principal Investigator for the NIH HEAL project on outcomes of infants with opioid exposure Dr. Ambalavanan has demonstrated exceptional mentorship, having trained multiple junior faculty including three with K08 awards, one with R01 funding, one with AHA SDG, and one with industry funding. He leads a basic science laboratory while managing single-center and multicenter observational and interventional clinical studies. The UAB neonatal program serves as a regional perinatal center with approximately 350 very low birth weight (VLBW) infant births per year (200+ extremely low birth weight infants/year) and participates in the NICHD Neonatal Research Network (where he serves as alternate center PI), the Global Network, and the MFMU Network. Within the Neonatal Research Network, he chairs the Budesonide in Babies subcommittee, co-chairs the Genomics subcommittee, and serves on the Late Hypothermia and MoCHA subcommittees.

پروفایل رسمی دانشگاه

Jeffrey Wozniakمشاهده پروفایل

استاد

University of Minnesota Twin CitiesUnited States

Jeffrey Wozniak serves as Professor and Director for Child & Adolescent Mental Health Research at the University of Minnesota's Department of Psychiatry & Behavioral Sciences, based at the Masonic Institute for the Developing Brain (2025 E River Pkwy, Minneapolis, MN 55414). His leadership oversees critical initiatives in pediatric mental health research within this dedicated neuroscience facility. Dr. Wozniak's research centers on Fetal Alcohol Spectrum Disorders (FASD) , investigating neurobehavioral impacts of prenatal alcohol exposure and developing clinical interventions for affected youth. His work bridges psychiatry and developmental neuroscience, emphasizing early diagnosis and family-centered treatment approaches for children with neurodevelopmental conditions. No scientific awards were documented in the provided biography excerpt. While his directorship implies supervision of research teams and grant management, specific advising roles or funded projects remain unlisted in the available text. His operational base—the Masonic Institute for the Developing Brain—functions as a multidisciplinary hub studying brain development trajectories from infancy through adolescence, with Dr. Wozniak steering its child mental health research agenda.

پروفایل رسمی دانشگاه

Julie Eisengartمشاهده پروفایل

دانشیار

University of Minnesota Twin CitiesUnited States

Dr. Julie Eisengart is an Associate Professor in the Department of Pediatrics at the University of Minnesota and serves as Director of the Neurodevelopmental Program in Rare Disease at the Masonic Institute for the Developing Brain. As a pediatric neuropsychologist, her work focuses on rare neurodegenerative childhood disorders, particularly lysosomal storage disorders such as mucopolysaccharidosis and adrenoleukodystrophy. Current affiliation: University of Minnesota, Department of Pediatrics Leadership role: Director of Neurodevelopmental Program in Rare Disease Her research explores the dynamic interplay between brain structure, biochemical abnormalities, and functional outcomes in rare diseases. Key projects include: Phase 1/2 trial for Gaucher disease type 2 (2020-2026) Long-term outcomes of hematopoietic cell transplantation for alpha-mannosidosis (2023-2025) Biomarker development for Sanfilippo syndrome progression (2021-2023) Hydrocephalus analysis in Hurler syndrome (2020-2022) Neurobehavioral links to brain connectivity in MPS I (2020-2021) Her work emphasizes patient-centered outcomes, including neurobehavioral symptoms and caregiver experiences, while contributing to UN Sustainable Development Goals through rare disease research. Recent publications focus on hematopoietic cell transplantation efficacy, neurocognitive biomarkers, and novel therapeutic approaches like Anakinra for Sanfilippo syndrome.

پروفایل رسمی دانشگاه

Kelly Kingمشاهده پروفایل

دانشیار

University of Minnesota Twin CitiesUnited States

Kelly King serves as an Associate Professor in the Department of Pediatrics at the University of Minnesota, with concurrent faculty appointments in the Division of Clinical Behavioral Neuroscience, Center for Neurobehavioral Development, and Masonic Institute for the Developing Brain. She holds the critical role of Training Director for Pediatric Neuropsychology, shaping clinical training programs within the institution. Her expertise centers on pediatric neuropsychological assessment and neurobehavioral development, with specialized focus on: Neurodevelopmental disorders in children Clinical behavioral neuroscience applications Child cognitive assessment methodologies Developmental neuropsychology interventions Pediatric brain-behavior relationships Neurodevelopmental diagnostic frameworks Dr. King actively contributes to interdisciplinary research and clinical operations through her leadership at the Center for Neurobehavioral Development and Masonic Institute for the Developing Brain. Her training directorship emphasizes mentorship in pediatric neuropsychology, though specific student names or grant details remain unreported in available materials.

پروفایل رسمی دانشگاه

Pınar DEMİR ASMAمشاهده پروفایل

استادیار

Üsküdar UniversityTurkey

Pınar DEMİR ASMA is an Assistant Professor in the Child Development Department at Uskudar University's Faculty of Health Sciences since 2024. She holds a Ph.D. in Psychology from Bolu Abant Izzet Baysal University (2024), an MSc in Mental Rehabilitation (Kocaeli University, 2020), and a BSc in Child Development (Istanbul Okan University, 2018). Her academic career includes roles as a Research Assistant (2018-2024) and current doctoral faculty member at Uskudar University. Child Development Social Development Emotional Development Cognitive Development Developmental Psychology Her recent publications focus on play behavior , psychological well-being , and self-injurious behaviors . Key trends include interdisciplinary approaches to early childhood development, emotional regulation in adolescents, and caregiver training in municipal settings. She has presented extensively at international and national conferences, including the International Play Congress (2025) and International Congress on Understanding Violence (2020). Supervising student theses Teaching courses like Developmental Psychopathology and Social-Emotional Development Serving as Deputy Head of Child Development Department (2024-present)

پروفایل رسمی دانشگاه

Lucia Carvelliمشاهده پروفایل

دانشیار

Florida Atlantic University - Boca RatonUnited States

Lucia Carvelli, Ph.D., is an Associate Professor of Neuroscience at the Harriet L. Wilkes Honors College and an Investigator at the FAU Brain Institute . She also holds a secondary appointment as an Associate Professor in Biomedical Science at the Charles E. Schmidt College of Medicine , Florida Atlantic University. Her research focuses on the molecular mechanisms of amphetamine action at dopaminergic synapses , with a particular emphasis on long-term and transgenerational effects of embryonal exposure to amphetamine and cocaine . Dr. Carvelli earned her Ph.D. in Molecular Pharmacology from the Institute of Pharmacological Research Mario Negri in Milan, Italy, in 1999. She completed postdoctoral training in molecular neuropharmacology at the University of Texas in San Antonio and membrane physiology at Vanderbilt University School of Medicine, followed by further studies at Vanderbilt University Medical School where she examined dopamine transporter regulation by synaptic proteins in C. elegans . Her scholarly work explores the epigenetic mechanisms of amphetamine , dopamine signaling pathways , and transgenerational epigenetic modifications using Caenorhabditis elegans as a model organism. Notably, her research has been funded by the NIH R01 (DA042156) grant , which aims to characterize the long-term and transgenerational effects of chronic amphetamine exposure during early development . Dr. Carvelli has received numerous honors, including the Alfredo Leonardi Award for Best PhD Student in 1999, and has held councilor positions in the International Transmembrane Transporter Society and Catecholamine Society . She has also served on study sections for the National Institute of Health , including the Avenir Program for Genetics or Epigenetics of Substance Use Disorders in 2017 and the Neurotransporters, Receptors and Calcium Signaling Study Section since 2018.

پروفایل رسمی دانشگاه

Melissa S Xanthopoulosمشاهده پروفایل

دانشیار بالینی

University of PennsylvaniaUnited States

Melissa S. Xanthopoulos is a Clinical Associate Professor of Psychiatry at the Perelman School of Medicine, University of Pennsylvania, and a psychologist at the Children’s Hospital of Philadelphia (CHOP). She serves as Co-Leader of the Continuous Positive Airway Pressure (CPAP) Quality Improvement Initiative and Director of the CPAP Adherence Program at CHOP. Her work focuses on implementation science, adherence to medical interventions, and behavioral strategies for sleep disorders, obesity, and developmental disabilities. BS in Kinesiology, Minor in Psychology - Pennsylvania State University, 1998 MS in Clinical Exercise Physiology - East Stroudsburg University, 1999 MS in Clinical Psychology (Health Psychology) - Drexel University, 2003 PhD in Clinical Psychology - Drexel University, 2006 Her research explores the intersection of psychosocial and physiological factors affecting health outcomes, particularly in children with chronic conditions like Down syndrome and pulmonary hypertension. She develops behavioral interventions for CPAP adherence, lifestyle modifications, and digital health solutions. Recent publications address CPAP quality improvement, physical activity barriers in youth with developmental disabilities, and behavioral strategies for sleep apnea and obesity. Her work spans sleep medicine, pediatrics, and health psychology. Active affiliations with CHOP’s Sleep Center, Pulmonary and Sleep Medicine Division, and Healthy Weight Program Interdisciplinary collaborations in immunology, cardiology, and neurodevelopmental research

پروفایل رسمی دانشگاه

Esther Louise Sabbanمشاهده پروفایل

استاد

New York Medical CollegeUnited States

Esther Louise Sabban, Ph.D. is a distinguished Professor in the Department of Biochemistry and Molecular Biology at New York Medical College's Graduate School of Biomedical Sciences. She also holds the prestigious Sidney E. Frank Distinguished Professorship in Psychiatry and Behavioral Sciences and is a Professor in Biochemistry and Molecular Biology at the School of Medicine. Her research spans multiple disciplines within neuroscience and stress physiology, with a particular focus on molecular mechanisms underlying stress-related disorders. Dr. Sabban earned her Ph.D. from New York University and holds an M.S. from Hebrew University. Her educational background provided the foundation for her extensive research career investigating the neurochemical basis of stress responses and their relationship to various disorders. Dr. Sabban's research primarily focuses on elucidating molecular mechanisms of stress-related disorders and developing potential therapies. Her laboratory investigates neurotransmitter regulation, particularly abnormalities in catecholamine neurotransmission involved in stress, cardiovascular disorders, Parkinson's disease, and depression. A significant portion of her work involves studying animal models for post-traumatic stress disorder (PTSD), with her lab being the first to provide proof of concept that intranasal delivery of neuropeptide Y or melanocortin 4 receptor antagonists can prevent the development of many PTSD-associated impairments. Her research also explores molecular adaptations of peripheral and central catecholaminergic systems to acute and chronic stress exposure, the influence of estrogen on stress responses, and the role of corticotrophin-releasing hormone family members and components of the renin-angiotensin system in stress regulation. Analysis of Dr. Sabban's recent publications reveals a strong emphasis on understanding stress resilience and susceptibility, with particular attention to sex differences, gut microbiome influences, and novel therapeutic approaches for PTSD. Her work spans multiple disciplines including neuroscience, molecular biology, endocrinology, and behavioral science, with a clear translational focus on developing interventions for stress-related disorders. The research demonstrates increasing sophistication in methodology, incorporating transcriptomics, microbiome analysis, and advanced behavioral testing. Dr. Sabban has made significant contributions to the field through her extensive publication record spanning several decades, with notable work on catecholaminergic systems in stress, neuropeptide Y research, and PTSD mechanisms. Her editorial work on examining mechanisms of PTSD using animal models demonstrates her leadership in the field. Her laboratory conducts preclinical studies on prophylactic, early intervention, and treatment approaches for PTSD using the single prolonged stress animal model. The research investigates molecular, behavioral, and neuroendocrine effects of traumatic stress with and without intranasal delivery of therapeutic agents, focusing on key brain regions involved in stress response including the locus coeruleus, hypothalamus, hippocampus, amygdala, and prefrontal cortex. This comprehensive approach to understanding stress mechanisms has positioned her laboratory at the forefront of translational stress research.

پروفایل رسمی دانشگاه

Neal Thomasمشاهده پروفایل

استاد

Pennsylvania State UniversityUnited States

Neal Thomas, MD, MSc, is a Professor at Penn State College of Medicine, holding appointments in both the Department of Pediatrics, Division of Critical Care Medicine, and the Department of Public Health Sciences. He serves as Associate Dean for Clinical Research and is affiliated with the Penn State Clinical and Translational Science Institute (CTSI), Center for Cannabis and Natural Product Pharmaceuticals (CCNPP), and Pediatric Cardiovascular Research Center. Dr. Thomas has held leadership roles in the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, including Chair (2020–present) and Vice-Chair (2018–2020), and was a key organizer of the Pediatric Acute Lung Injury Consensus Conference (2012–2015). Education: MD, MSc Dr. Thomas specializes in clinical research involving critically ill children, with a focus on pediatric acute respiratory distress syndrome (PARDS), pediatric sepsis, and septic shock. His work spans genetic studies of surfactant protein variants, acute kidney injury in proteinuric children, and neurobehavioral outcomes after traumatic brain injury. He has led NIH- and FDA-funded clinical trials and contributed to over 300 peer-reviewed publications. The 15 most recent articles reflect his expertise in pediatric critical care. Key themes include PARDS, sepsis, congenital heart surgery outcomes, traumatic brain injury recovery, and acute kidney injury epidemiology. His studies employ multicenter registries, randomized trials, and longitudinal frameworks to address clinical challenges in underweight/obese children and leukemia/HCT recipients. Grants & Projects: NIH, FDA, and foundation-funded trials (e.g., Calfactant for ALI in pediatric leukemia patients) Research on surfactant protein-A genetic variants and lung host defense Labs & Collaborations: Dr. Thomas collaborates with the Pediatric Cardiovascular Research Center and leads initiatives through the PALISI Network, which has produced over 200 publications. His work intersects with UN Sustainable Development Goals (SDGs) related to health and well-being.

پروفایل رسمی دانشگاه